Therapeutic peptide developed for triple-negative breast cancer
Drug Target Review,
Scientists demonstrate how disrupting the Cx26 molecular complex in triple-negative breast cancer cells slowed tumour growth.
Scientists demonstrate how disrupting the Cx26 molecular complex in triple-negative breast cancer cells slowed tumour growth.
Prevention and treatment of COVID-19 and its variants may one day be a few spritzes of nasal spray away, according to one…